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ApoptosisThe existence of the bcl-2 (B-cell lymphoma-2) gene was reported nearly 30 years ago. Yet, Bcl-2 family
group of proteins still surprises us with their structural and functional diversity. Since the discovery of the
Bcl-2 family of proteins as one of the main apoptosis judges, the precise mechanism of their action remains
a hot topic of intensive scientiﬁc research and debates. Although extensive work has been performed on the
role of mitochondria in apoptosis, more and more studies point out an implication of the endoplasmic
reticulum in this process. Interestingly, Bcl-2 family proteins could be localized to both the mitochondria
and the endoplasmic reticulum highlighting their crucial role in apoptosis control. In particular, in these
organelles Bcl-2 proteins seem to be involved in calcium homeostasis regulation although the mechanisms
underlying this function are still misunderstood. We now assume with high degree of certainty that the
majority of Bcl-2 family members take part not only in apoptosis regulation but also in other processes im-
portant for the cell physiology brieﬂy denominated as “non-apoptotic” functions. Drawing a complete and
comprehensive image of Bcl-2 family requires the understanding of their implications in all cellular process-
es. Here, we review the current knowledge on the control of calcium homeostasis by the Bcl-2 family at the
endoplasmic reticulum and at the mitochondria. Then we focus on the non-apoptotic functions of the Bcl-2
proteins in relation with the regulation of this versatile intracellular messenger. This article is part of a Special
Issue entitled: 12th European Symposium on Calcium.
© 2013 Elsevier B.V. All rights reserved.1. The Bcl-2 family of proteins and apoptosis
Historically, bcl-2 (B-cell lymphoma-2) gene was discovered at a
chromosomal translocation, t(14;18), associated with B-cell follicular
lymphoma. This translocation places bcl-2 under the control of the
immunoglobulin gene enhancer leading to abnormal high-level expres-
sion of Bcl-2 [1–3]. However, contrary to other oncogenes characterized
so far, Bcl-2 acts by inhibiting cell death rather than promoting cell
proliferation [4]. Bcl-2 was thus initially characterized as a mitochon-
drial resident protein that blocks apoptotic programmed cell death
[5]. Since the discovery of Bcl-2, extensive work on various animal
models, from worms to mammals, uncovered a family of proteins in-
volved in the control of apoptosis and sharing structural homology
with the canonical member Bcl-2 [6]. In vertebrates, members of theopean Symposium on Calcium.
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characterized by the presence of at least one Bcl-2 homology (BH)
domain. According to their function in apoptosis, Bcl-2 family mem-
bers are designated as anti- or pro-apoptotic. Anti-apoptotic proteins
(e.g. Bcl-2, Bcl-xL, and Mcl-1) contain four BH domains and a hydro-
phobic transmembrane (TM) domain essential for their localization
into biological membrane. Pro-apoptotic proteins can be further
subdivided into two groups. The effector proteins Bax and Bak contain
four BH domains and a TM domainwhereas BH3-only proteins (e.g. Bad,
Bid, and Bik) possess just one BH domain and no TM domain with the
exception of Bik and Hrk [7,8].
The Bcl-2 family proteins play a crucial role in the control and the
execution of the intrinsic, or mitochondrial, pathway of apoptosis. In
this process, some death stimuli (e.g. growth factor deprivation, and
DNA damage) activate BH3-only proteins which in turn lead to the
activation of Bax and/or Bak either directly or by inhibiting anti-
apoptoticmembers. ActivatedBax/Bak thenoligomerize at themitochon-
dria to induce outer mitochondrial membrane (OMM) permeabilization
and release into the cytosol of apoptotic factors (e.g. cytochrome c and
AIF) which promote caspase activation and subsequent apoptosis execu-
tion. Anti-apoptotic members of Bcl-2 family are able to prevent OMM
permeabilization via a direct inhibitory interaction with pro-apoptotic
members [8].
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Although the mitochondrion is a key organelle for promoting
apoptosis, a growing body of evidence underlies the involvement of
endoplasmic reticulum (ER) in this process. The ER is the major site
of folding, modiﬁcation, and trafﬁcking of proteins as well as the
main store for intracellular Ca2+. These functions of the ER are tightly
connected as Ca2+ is required for protein synthesis in almost every
cell type. In the ER, Ca2+ supports early protein processing and
protein glycosylation. In addition, Ca2+ may also be implicated in
subunit assembly and protein folding [9]. Thus, the reduction of ER
Ca2+ level can induce the accumulation and aggregation of unfolded
proteins, a condition referred to as ER stress. To face this stress, cells
activate a prosurvival response known as the Unfolded Protein
Response (UPR) to reduce the accumulation of unfolded protein.
However if the UPR's mechanisms are insufﬁcient to decrease
unfolded protein load, the UPR activates apoptosis [10]. In this case,
components of the UPR induce apoptosis via the inactivation of Bcl-2
and the activation of several BH3-only proteins including Bim, Bad,
Bik and Puma which then activate Bax and Bak to promote cytochrome
c release from the mitochondria. Interestingly, a cross-talk exists
between the UPR and apoptosis as Bax/Bak have been proposed to
participate in early events of the UPR [11].
Moreover a number of stresses, including ER stress, can lead to the
release of the ER Ca2+ store and subsequent increase of cytosolic
Ca2+ levels [10,12]. Cytosolic Ca2+ elevation could in turn induce apo-
ptosis via several pathways independent or not from the mitochondria.
The ﬁrst one is triggered by the caspase-12 independently of mito-
chondria. This caspase localized at the ER [13,14] can be cleaved and
activated by the Ca2+-dependent protease, Calpain [15]. Activated
caspase-12 then processes downstream caspases leading to apoptosis
independently of OMM permeabilization [16].
Secondly, [Ca2+] rise into the cytosol may lead to OMM perme-
abilization through BH3-only protein activation. In particular, Calpain-
mediated Bid cleavage into its active form tBid was reported to induce
apoptosis in a Bax-dependent manner [17]. In addition, Calpain cleav-
age of Bcl-2 and Bcl-xL N-terminus reduces their anti-apoptotic activity
and even promotes Bcl-2 conversion into a pro-apoptotic proteinwhich
promotes cytochrome c release on its own [18]. Bad is another BH3-only
member which could be activated in response to Ca2+ elevation. Under
physiological conditions, Bad is phosphorylated and sequesters in the
cytosol by 14–3–3 proteins [19]. However, elevation of cytosolic Ca2+
levels activates the Ca2+-dependent phosphatase, Calcineurin (also
known as PP2B) which dephosphorylates Bad therefore activating the
intrinsic mitochondrial pathway [20]. Interestingly, it has also been
shown that a slight increase of Ca2+ could, on the contrary, promote
Bad phosphorylation and sequestration by 14–3–3 via the activation
of the Ca2+/Calmodulin dependent protein kinase kinase (CaMKK)
highlighting the versatility of Ca2+ signaling in cell fate [21].
Finally, massive Ca2+ release from the ER can directly trigger
cytochrome c release from the mitochondria. Indeed, the ER and the
mitochondria have long been known to be tightly associated [22,23].
More recent research established that ER membranes are in close
contact with mitochondria, forming microdomains called MAM for
mitochondria-associated membranes [24]. MAM are enriched in trans-
membrane proteins such as PACS-2 orMitofusin-2whichdirectly tether
the ER and the mitochondria thus creating a physical interaction be-
tween them [25,26]. These contact points are crucial for lipid and
Ca2+ exchanges between ER and mitochondria. Inositol 1,4,5-trisphos-
phate receptors (IP3R) located at the ER membrane play an essential
role in ER to mitochondria Ca2+ trafﬁcking [27,28]. In MAM, IP3R
seems to be part of a protein complex with Grp75 and the mitochon-
drial Voltage Dependent Anion Channel (VDAC) that promotes Ca2+
exchange between ER and mitochondria [29]. [Ca2+] in MAM can
reach a very high level compared to the cytosolic concentration [30]
which is consistent with a specialized function in Ca2+ transfer betweenER and mitochondria. Indeed, the recently identiﬁed Mitochondrial
Calcium Uniporter (MCU) [31,32] requires a high level of Ca2+ to open
due to its interaction with MICU1 which acts as a gatekeeper by setting
a threshold for Ca2+ entry into mitochondria [33]. Thus, Ca2+ released
through IP3R in MAM can be rapidly uptaken into the mitochondria
by VDAC and MCU to enter mitochondrial matrix [34]. Interestingly,
IP3R has been acknowledged to be required for apoptosis in some
cases [35–38]. Therefore, upon a stress inducing massive Ca2+ release
through IP3R, mitochondria face very high level of calcium and uptake
it to buffer cytosolic Ca2+. When Ca2+ accumulates in the mitochondria
it binds to Cyclophilin D which induces the opening of the permeability
transition pore (PTP) and ﬁnally leads to cytochrome c release [39].
3. Regulation of ER Ca2+ homeostasis by Bcl-2 proteins
The concept that members of the Bcl-2 family could be localized
to the ER [40] and control apoptosis through ER Ca2+ homeostasis
regulation, emerged almost two decades ago. However, in spite of
increasing number of studies, the mechanisms by which the Bcl-2
proteins exert this function are still unclear and subject to controversy
(Fig. 1).
3.1. Regulation by anti-apoptotic proteins
Theﬁrst observation suggesting a role for Bcl-2 on intracellular Ca2+
homeostasis was made in 1993 [41]. The authors demonstrated that, in
Interleukin-3 (IL-3)-dependent hematopoietic cells, IL-3 withdrawal
induces apoptosis by a Ca2+ transfer from the ER to the mitochondria.
In this model, Bcl-2 overexpression prevents apoptosis and blocks this
Ca2+ ﬂux. In this study, the thapsigargin-releasable Ca2+ pool before
IL-3 withdrawal was not affected by Bcl-2 suggesting that Bcl-2 does
not alter ER Ca2+ content but rather acts on Ca2+ release from the ER.
The year after, two other studies concluded that Bcl-2 decreases Ca2+
release from the ER. The ﬁrst showed that Bcl-2 prevents cytosolic
Ca2+ increase induced by serum withdrawal in NIH3T3 cells [42]. The
second reported that Bcl-2 was able to inhibit thapsigargin-induced
apoptosis [43]. Here the authors showed that Bcl-2 reduces Ca2+ efﬂux
from the ER following thapsigargin treatment but that this effect
was not due to alteration in Ca2+ homeostasis within the ER lumen.
The same effect was observed upon hydrogen peroxide treatment
suggesting that Bcl-2 can reduce Ca2+ release from the ER to prevent
apoptosis induced by various stresses [44,45]. However, subsequent
studies showed that Bcl-2 is able to increase Ca2+ uptake in the ER
and then enhanced ER Ca2+ load under certain conditions. He and
colleagues showed that overexpression of Bcl-2 maintains ER Ca2+
homeostasis when the sarco/endoplasmic reticulum Ca2+-ATPase
(SERCA) is inhibited by thapsigargin or when the extracellular [Ca2+]
is decreased [46]. Here, Bcl-2 does not seem to prevent SERCA inhibition
so the authors concluded that Bcl-2 could mediate Ca2+ uptake in the
ER. They proposed that Bcl-2, by preventing oxidative damage to the
ER membrane, could decrease Ca2+ leak through the ER and thus in-
crease Ca2+ loading capacity of the ER. They also hypothesized that
this effect of Bcl-2 could be due to the formation of cation-selective
channel in lipid bilayer by Bcl-2 or Bcl-xL [47,48] thus allowing Ca2+
entry into the ER lumen. However, this hypothesis does not take into
account the existing calcium gradient across the ERmembrane, render-
ing unlikely the passive calcium transport through Bcl-2 channels.
Other studies also reported an increased Ca2+ load of the ER when
Bcl-2 is overexpressed but in this case it was attributed to an increase
level of SERCA expression [49,50]. Interestingly, the authors also de-
scribed an interaction between Bcl-2 and SERCA which was proposed
to enhance SERCA activity [44]. Such interaction was also suggested
in Xenopus oocytes where Bcl-2 was shown to desensitize SERCA to
thapsigargin thanks to its BH4 domain [51]. In all these studies, it was
assumed that the anti-apoptotic effect of Bcl-2 was mediated by a
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Fig. 1. Schematic representation of the different models for Bcl-2 family activity on ER Ca2+ homeostasis. (A) In this model, Bcl-2 reduces cytosolic [Ca2+] to prevent apoptosis
induction. Bcl-2 could act either by increasing SERCA activity or by reducing IICR. Bcl-2 may exert its inhibitory activity on IP3R via a direct interaction with the modulatory and
transducing domain of the receptor. Conversely, activated Bax and Bak are proposed to induce Ca2+ release from the ER. (B) In this model, Bcl-2 reduces ER Ca2+ content to prevent
massive Ca2+ release which could trigger apoptosis. Bcl-2 is proposed to increase Ca2+ leak from the ER by promoting IP3R phosphorylation or by directly inducing Ca2+ leak alone
or in combination with a BH3-only protein. Bcl-2 could also reduce SERCA activity by a direct interaction. Bax and Bak may counteract the effect of Bcl-2 by a direct inhibitory
interaction. Finally, Bcl-xL could act on BI-1 to increase Ca2+ leak from the ER with BI-1 acting as a Ca2+ channel or as an IP3R sensitizer. (C) In this model, anti-apoptotic proteins
promote survival by enhancing ER-mitochondria coupling. They are proposed to enhance IICR at low [IP3] to stimulate bioenergetics whereas at high [IP3] they could prevent
apoptosis by reducing IICR. This effect may be mediated by a direct interaction with the C-terminus of IP3R. Dashed lines represent a reduction of the calcium ﬂux. Bold lines
represent an increase of the calcium ﬂux. Red and blue arrows represent activation and inhibition respectively. IP3R: inositol 1,4,5-trisphosphate receptor; SERCA: sarco/endoplasmic
reticulum Ca2+-ATPase; BI-1: Bax-inhibitor-1; IICR: IP3-induced calcium release.
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reducing Ca2+ release from the ER (Fig. 1A).
Nevertheless, in 2000 a new mechanism of action for Bcl-2 at the
ER emerged when two groups showed that Bcl-2 was able to decrease
ER Ca2+ content [47,48]. In their study, Pinton and colleagues demon-
strated that Bcl-2 overexpression reduces IP3-induced Ca2+ release
(IICR) and attributed this effect to a lower ER Ca2+ content due to
increased Ca2+ leak from the ER [52]. Surprisingly, the authors did not
observe any variation in cytosolic [Ca2+] despite the detection of
decreasedmitochondrial Ca2+ uptake. Foyouzi-Yousseﬁ and colleagues
also described a reduced ER Ca2+ content in Bcl-2 overexpressing cells
[53]. As ER [Ca2+] decrease is a signal for capacitative Ca2+ entry,
authors showed that Bcl-2 enhances unstimulated Ca2+ inﬂux and
then induced elevated basal cytosolic [Ca2+]. As for the previous study,
it was shown that decreased ER [Ca2+] is a consequence of increased
Ca2+ leak from the ER rather than Ca2+ uptake reduction. In both
cases authors argued that formation of a cation-selective channel by
Bcl-2 may be responsible for the increased Ca2+ leak (Fig. 1B). Two
subsequent studies also concluded that Bcl-2 could decrease ER Ca2+
content. In the ﬁrst it was demonstrated that Bcl-2 overexpression
increases Ca2+ leak but also downregulates SERCA and Calreticulin
expression to reduce ER Ca2+ content [54]. In the second, using a new
genetically-encoded Ca2+ sensor, Palmer and colleagues measured
[Ca2+] within the ER lumen. They found that Bcl-2 decreases ER Ca2+
content and, as a consequence, alters IICR [55].
In thismodel it was proposed that reduction of Ca2+ levelwithin the
ERmediates the anti-apoptotic activity of Bcl-2 by reducing the amount
of releasable Ca2+ available to induce apoptosis. Foyouzi-Yousseﬁ and
colleagues also speculated that the increased cytosolic [Ca2+] theyobserved could promote cell survival by the CaMKK-dependent phos-
phorylation of Bad.
However, the idea according to which this effect is mediated by
Bcl-2 pore formation was challenged when Chami and colleagues
showed that a Bcl-2 chimera protein containing the pore domain of
Bax has the same effect on ER Ca2+ homeostasis as the wild-type
Bcl-2 [56]. Another possible mechanism emerged from a study
which showed that, in contrast to what was proposed earlier, Bcl-2
can interact with and destabilize SERCA [57] (Fig. 1B). Another idea
was further put forward to explain the reduction of ER Ca2+ content
by Bcl-2. In their study, Bassik and colleagues proposed that Bcl-2
phosphorylation within an unstructured loop between its BH4 and
BH3 domains can modulate its ability to decrease ER Ca2+ content
[58]. They showed that in cells expressing a non-phosphorylatable
mutant of Bcl-2 (Bcl-2 AAA) the ER Ca2+ level is lower than in Bcl-2
expressing cells due to higher Ca2+ leak. In this regard Bcl-2 AAA is
more efﬁcient at protecting cells from Ca2+-dependent apoptotic
stimuli than the wild-type protein. At last, they demonstrated that
phosphorylation of Bcl-2 impairs its interaction with Bax and BH3-
only proteins and provided evidence suggesting that Bcl-2 interaction
with the BH3-only proteins was required to promote the reduction of
ER Ca2+ content (Fig. 1B). However how a complex between Bcl-2
and a BH3-only can induce Ca2+ leak through the ER membrane is
not discussed and remains elusive.
Finally, it has been proposed that Bax Inhibitor-1 (BI-1) may be
the downstream target of Bcl-xL to lower ER [Ca2+]. Indeed, Xu and
colleagues demonstrated that BI-1 is required for ER calcium content
reduction induced by Bcl-xL overexpression [59] (Fig. 1B). BI-1 was
shown to increase calcium leak from the ER in a pH-dependent
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channel pore with its C-terminus [61] or by interacting with IP3R to
sensitize the channel to low [IP3] [62].
Thus, so far, the molecular mechanism by which Bcl-2 can reduce
Ca2+ level within the ER is still a matter of debate and should be
further investigated.
Finally, the group of C.W. Distelhorst proposed that Bcl-2 could
regulate calcium homeostasis at the ER by directly interacting with
IP3R. In a work published in 2004 they demonstrated that Bcl-2 is
able to decrease IICR without affecting ER calcium level. In a convinc-
ing manner they showed that Bcl-2 directly interacts with IP3R,
forming a complex with the receptor. As a consequence, they de-
scribed that Bcl-2 is able to reduce the channel open probability of
IP3R [63]. These results were conﬁrmed by another study where the
authors notably showed that ER-targeted Bcl-2 has the same effect
as wild-type Bcl-2 on Ca2+ homeostasis [64]. Interaction between
Bcl-2 and IP3R was further characterized and it was demonstrated
that Bcl-2 binds to the modulatory and transducing domain of IP3R
between the residues 1347–1426 in the middle of the protein [65]
(Fig. 1A). Furthermore, Bcl-2 interacts with IP3R via its BH4 domain
and it has been shown that the BH4 domain alone was sufﬁcient to
decrease IICR [66]. At last, a recent study comparing the BH4 domains
of Bcl-2 and Bcl-xL has identiﬁed a crucial residue within Bcl-2 which
seems essential for its regulatory activity on IICR [67]. Contrary to
Bcl-2, the BH4 domain of Bcl-xL was able neither to bind to the mod-
ulatory and transducing domain nor to reduce Ca2+ release through
IP3R. The authors found the Lys17 residue of Bcl-2 to be critical for
the activity of Bcl-2 on IP3R since its mutation in aspartate, as in the
BH4 domain of Bcl-xL, abolishes the activity of Bcl-2 BH4 domain on
Ca2+ signaling.
However, Bcl-xL was also shown to interact with IP3R but at a dif-
ferent site as it binds the C-terminus of IP3R. This interaction was
shown to sensitize IP3R to low concentrations of IP3 thus enhancing
Ca2+ oscillation in the cytosol. IP3R sensitization stimulates mito-
chondrial bioenergetics allowing the authors to propose that Bcl-xL
could promote survival by enhancing ER-mitochondria coupling and
cellular metabolism [68]. In this case, Bcl-xL was also reported to
decrease ER Ca2+ content but this effect does not seem to be relevant.
Indeed, the same team showed two years later that Bcl-xL interacts
with the three IP3R isoforms but reduces ER Ca2+ content only in
cells expressing IP3R3. However, Bcl-xL sensitizes all IP3R isoforms
to IP3 and enhances cytosolic Ca2+ oscillation and apoptosis resis-
tance whatever isoform is expressed [69]. Therefore it is more likely
that Bcl-xL action is mediated rather by its interaction with IP3R
than by decreasing ER Ca2+ content (Fig. 1C).
These differences between Bcl-xL and Bcl-2 could be attributed, as
exposed above, to the differences between the BH4 domains of these
proteins. Thus, depending on their BH4 domain, anti-apoptotic mem-
bers could interact at different sites within IP3R thus regulating the
channel activity in a different manner (for extensive discussion on
the topic see [70]).
Nevertheless, Bcl-2 and Mcl-1 seem also able to bind to the
C-terminus region of IP3R and to regulate Ca2+ homeostasis in a man-
ner similar to Bcl-xL highlighting the complexity of Bcl-2 family me-
diated regulation of IP3R [71,72] (Fig. 1C).
3.2. Regulation by pro-apoptotic members
Pro-apoptotic proteins are also able to localize at the ER and act on
ER Ca2+ homeostasis. In 2001, Pan and colleagues ﬁrst proposed a
link between Bax and ER Ca2+ signaling since apoptosis induced by
overexpression of Bax in CHO cells was correlated to a depletion of
ER Ca2+ store [73]. However they argued that the depletion of the ER
Ca2+ store rather than cytosolic [Ca2+] increase is responsible for
apoptosis induction in their model. The year after Bax and Bak were
shown to localize at the ER where they induce ER Ca2+ depletion andsubsequent cytochrome c release due to Ca2+ accumulation in the mi-
tochondria [74]. Bax seems to be required to induce Ca2+-dependent
apoptosis as Bax-null cells did not elicit ER Ca2+ pool reduction and
subsequent apoptosis induced by the staurosporine [75]. Moreover,
the group of C. Thompson found that ER stress can induce Bax and
Bak oligomerization at the ER leading to caspase-12 activation [76].
Interestingly, they showed that the targeted expression of Bak was suf-
ﬁcient to trigger ER Ca2+ depletion and subsequent caspase-12 activa-
tion even in the absence of endogenous Bax and Bak. A more recent
study is consistent with an activity of Bak at the ER as it was shown
that ER-targeted Bak is able to activate BH3-only proteins and subse-
quent cytochrome c release in part via ER Ca2+ release [77]. All these
studies therefore assess that once activated Bax and Bak could trigger
Ca2+ release from the ER to induce apoptosis (Fig. 1A). However, as
for the anti-apoptotic proteins contradictory results concerning the
role of pro-apoptotic proteins at the ER exist. Indeed, the group of S.
Korsmeyer found that in MEF cells deﬁcient for Bax and Bak, ER Ca2+
content was signiﬁcantly reduced suggesting that Bax and Bak act at
the ER by increasing [Ca2+] in the lumen of the ER [78]. A few years
later, they proposed a model to explain the effect of Bax and Bak on
ER Ca2+ content. They showed that in cells lacking Bax and Bak IP3R1
is hyperphosphorylated on Ser 1755. This PKA-dependent phosphoryla-
tion renders IP3R sensitive to basal IP3 concentration thus increasing
Ca2+ leak from the ER. They also found that in the absence of Bax and
Bak the interaction between Bcl-2 and IP3R was enhanced and that
bcl-2 knockdown reduces IP3R phosphorylation in these cells [79]. So
this group proposed that at the ER, Bcl-2 might induce IP3R phosphory-
lation thus promoting Ca2+ leak and ER Ca2+ content reductionwhere-
as Bax and Bak, by interacting with Bcl-2, could counteract IP3R
phosphorylation (Fig. 1B).
Finally, besides the multidomain proteins of the Bcl-2 family,
the BH3-only protein Bik is also localized at the ER, thanks to its
C-terminus TM domain, where it can induce cytochrome c release
from the mitochondria [80]. Surprisingly, in this ﬁrst study the authors
argued that Ca2+ was not involved in this process. However, in a more
recent study, they showed that Bik can induce Ca2+ release from the ER
by promoting Bax and Bak localization and oligomerization at the ER
[81] (Fig. 1A).
At the light of these conﬂicting results, it is difﬁcult to decipher a
commonmechanism of action for the Bcl-2 family at the ER. Differences
in the cell models aswell as the detectionmethods used by the different
groups should be taken into account explaining partially the divergence
in the proposed models. Despite these discrepancies, it remains clear
that multiple members of Bcl-2 proteins may act as key regulators of
calcium homeostasis at the ER. Indeed, all studies at least agree on the
fact that anti-apoptotic proteins are able to reduce the amount of calci-
um released from the ER upon apoptotic stress whereas pro-apoptotic
has the opposite effect.
4. Regulation of mitochondrial Ca2+ homeostasis by
Bcl-2 proteins
Although ER is the main store of Ca2+ in the cell, mitochondria
also play a critical role in Ca2+ homeostasis. As mentioned in
Section 2, mitochondria can rapidly uptake Ca2+ present in the cyto-
sol acting as a buffer when cytosolic [Ca2+] increases. In mitochon-
dria Ca2+ enhances substrate uptake, the rate of NADH production
and the activity of the ATP synthase as well as those of the pyruvate,
ketoglutarate and isocitrate dehydrogenases of the TCA cycle thus pro-
moting mitochondrial metabolism and ATP production [82]. However,
Ca2+ overload is detrimental as it impairs mitochondrial respiration
and leads to membrane potential drop, mitochondria swelling and
ﬁnally cytochrome c release. Thus, given the role of the Bcl-2 family
on the control of cell fate it can be assumed that this group of proteins
can also modulate Ca2+ homeostasis directly at the mitochondria.
Indeed, several studies have revealed that Bcl-2 proteins could act
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sensus exists concerning the mechanisms underlying this function
(Fig. 2).
The ﬁrst evidence for a role of Bcl-2 on mitochondrial Ca2+
homeostasis was provided in a study on neural cells. In this model,
it was shown that overexpression of Bcl-2 allows mitochondria to up-
take more Ca2+ without any mitochondrial respiratory impairment
suggesting that Bcl-2 can protect mitochondria from Ca2+ overload
[83]. Similar results showing that Bcl-2 enhances the capacity of mito-
chondria to store Ca2+ were obtained by two other groups [45,50,84].
One of these further showed that Bcl-2 in fact induces a reduction
of mitochondrial Na+/Ca2+ exchanger activity leading to decreased
Ca2+ efﬂux from the mitochondria [85] (Fig. 2A). However, other
studies found that Bcl-2 had no effect on Ca2+ uptake by the mito-
chondria [58] or even decreases this process although excessive
Bcl-2 amount could be detrimental for mitochondria [64].
Concerning the pro-apoptotic members, only few cases depict a
role in mitochondrial Ca2+ homeostasis. For instance, it has been
shown that Bax can enhance cytochrome c release induced by Ca2+
on isolated mitochondria suggesting that Bax may contribute to
Ca2+ entry in this organelle [86]. Another study also concluded that
Bax and Bak increase [Ca2+] within mitochondria [74] (Fig. 2B). On
the contrary it has also been proposed that Bax can promote Ca2+
release from the mitochondria to induce Ca2+ waves in the cell and
then enhance the apoptotic response [87] (Fig. 2A).
So far, the mechanism by which Bcl-2 family members can act on
mitochondrial Ca2+ homeostasis is still unknown. As at the ER it can
be speculated that the channel properties of the Bcl-2 proteins could
be implicated in this function, although Bcl-2 and Bcl-xL channels
seem more permeable to monovalent cations and Bax and Bak
channel to monovalent anions [88]. One other interesting hypothesis
emerged from the fact that Bcl-2 proteins have been shown to inter-
act with VDAC. This channel is the most abundant protein of the OMM
and is now acknowledged to be responsible for the import of Ca2+
across the OMM [89]. VDAC can be found in two states, an open
state where it is mainly permeable to anions and metabolites and a
closed state where cations, and in particular Ca2+, could freely per-
meate the channel [90,91]. The ﬁrst study reporting such interaction
demonstrated that Bcl-xL, Bax and Bak are able to bind to VDAC.
While Bcl-xL closes VDAC, Bax and Bak on the contrary promote
VDAC opening [92]. The year after, the same group showed that the
BH4 domain of Bcl-xL and Bcl-2 was required for exerting their inhib-
itory effect on VDAC opening [93]. Surprisingly, in this paper authors
showed that Bcl-xL could inhibit loss of membrane potential andBcl-xL promotes VDAC closure
Bcl-2 reduces Ca2+ effluxBax promotes Ca2+ release 
Bcl-
Bax/Bak en
Ca2+ upt
BA
Fig. 2. Schematic representation of the different models for Bcl-2 family activity on mito
mitochondrial capacity to uptake Ca2+. Bcl-2 could reduce the activity of the mitochondrial N
Ca2+ entry into the mitochondria. Conversely, Bad may induce VDAC opening whereas Bax m
this model, anti-apoptotic members prevent mitochondrial Ca2+ overload. Bcl-xL could pro
VDAC closure and Bax/Bak may promote mitochondrial Ca2+ uptake. Dashed lines represent
and blue arrows represent activation and inhibition respectively. VDAC: Voltage Dependencytochrome c release from isolated mitochondria submitted to a high
[Ca2+]. Therefore, if Bcl-xL promotes VDAC closure it can be assumed
that it promotes Ca2+ entry into mitochondria and thus may not pre-
vent apoptosis in this case. This group also showed that the BH3-only
protein Bim could also interact with VDAC and promote its opening
[94]. Another recent study also concluded that Bcl-xL could promote
VDAC closure via an interaction with the N-terminus domain of the
channel [95]. Thus, in this model, anti-apoptotic proteins might en-
hance Ca2+ entry into mitochondria whereas pro-apoptotic proteins
might inhibit it (Fig. 2A). However this proposal does not ﬁt the largely
accepted idea of Ca2+-sensitive mitochondrial PTP opening. According
to this model one could postulate that pro-apoptotic should enhance
Ca2+ entry into mitochondria to promote cell death and then promote
the closure of VDAC. Of note, it has been shown that promoting the
closed state of VDAC accelerates the Ca2+-induced PTP opening [96].
More consistent with the Ca2+-sensitive PTP opening, Bcl-xL was
shown to promote the open state of VDAC [97] while the BH3-only
tBid on the contrarywas proposed to close the channel [98]. In addition,
Bcl-xL speciﬁcally targeted to the mitochondria was shown to be sufﬁ-
cient to protect cells fromapoptosis induced by Ca2+-dependent stress-
es such as H2O2 treatment suggesting it may prevent Ca2+ entry into
mitochondria through VDAC [99]. Moreover, a recent study has
implicated VDAC in Ca2+-dependent death induced by Bad [100].
In this paper, Roy and colleagues showed that upon ceramide and
staurosporine treatment Bad was dephosphorylated to induce apopto-
sis independently of Bax and Bak. Apoptosis in this case relies on Ca2+
and is triggered by the Ca2+-dependent PTP opening. Interestingly, in
these conditions, Bad targets Bcl-xL at the mitochondria and reduces
its interaction with VDAC. Thus by breaking Bcl-xL/VDAC interaction
Bad may promote VDAC closure and then Ca2+ entry into the mito-
chondria to induce PTP opening (Fig. 2B).
Through all these studies it appears that the exact role of Bcl-2
proteins on VDAC regulation remains largely unclear. Moreover,
results presented here provide only indirect clues for an implication
of the Bcl-2 family of proteins on mitochondrial Ca2+ homeostasis
via VDAC regulation. Taking into account that VDAC is also proposed
to participate in apoptosis by forming pores in the OMM alone or in
combination with Bax to induce cytochrome c release [101], it becomes
particularly difﬁcult to decipher the mechanism of action of Bcl-2 pro-
teins on VDAC activity as they can probably act on both VDAC oligomer-
ization and Ca2+ ﬂuxes through the channel. Nevertheless, given the
importance of Ca2+ signaling in mitochondria it can be of particular
interest to look directly at the ability of Bcl-2 proteins to control Ca2+
homeostasis in this organelle.xL promotes VDAC opening
hance
ake
tBid promotes VDAC 
closure
: VDAC
: Anti-apoptotic
: Pro-apoptotic
: BH3-only
: Na+/ Ca2+ exchanger 
chondrial Ca2+ homeostasis. (A) In this model, anti-apoptotic members increase the
a+/Ca2+ exchanger and Bcl-xL could promote VDAC closure suggesting it may increase
ay promote Ca2+ release from the mitochondria to amplify apoptotic response. (B) In
mote VDAC opening suggesting it may reduce Ca2+ entry. Conversely, tBid may induce
a reduction of the calcium ﬂux. Bold lines represent an increase of the calcium ﬂux. Red
t Anion Channel.
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Beyond their role in apoptosis, there is a growing body of evidence
suggesting that Bcl-2 proteins are involved in numerous other cellular
processes. However, the mechanisms allowing Bcl-2 proteins to exert
their non-apoptotic functions are poorly understood. Here, we will
discuss the implication of the regulatory activity of Bcl-2 proteins
on Ca2+ homeostasis as a possible mechanism for such functions
(Table 1).
5.1. Cell cycle
The cell cycle is the process by which cells divide through a series of
events leading to DNA replication and cytokinesis. Cell cycle is divided
in four phases, the G1 phase, the S phase, the G2 phase (collectively
forming the interphase) and the mitosis (M phase). Between the end
of mitosis and the G1 phase, cells can enter a quiescent state, known
as the G0 phase, were they stop dividing. At the molecular level, the
cell cycle is mainly regulated by Cyclin and Cyclin-dependent kinases
(CDK) that associate in a speciﬁc manner to drive the different phases
of the cell cycle.
The implication of Bcl-2 in the cell cycle was quickly suggested
after its discovery as in the absence of IL-3 Bcl-2 overexpressing
cells not only delayed the onset of apoptosis but are also arrested
in G1 phase [4]. Further investigations conﬁrmed this implication
of Bcl-2 in cell cycle control. In particular, it has been shown that
Bcl-2 deﬁcient cells have an accelerated cell cycle while Bcl-2
overexpression retards the G0/S transition [102]. This was correlated
to an increased level of the CDK inhibitor p27 and a downregulation
of the nuclear factor of activated T-cells (NFAT) activity. Bcl-xL has
the same effect on the cell cycle [103] and it has been conﬁrmed
that the effect of anti-apoptotic proteins on the cell cycle is mediated
by elevation of p27 level and subsequent inhibition of the CDKs re-
quired for G1 phase progression [104]. This effect can be counteracted
by Bax and Bad [103,105]; conversely Bax overexpression promotes S
phase entry due to lower level of p27 [106]. Thus, anti- and pro-
apoptotic exert opposite effects on the cell cycle at least in part by
controlling p27 level. However, it has been shown that the anti-
apoptotic function of Bcl-2 is independent from its action on the cell
cycle. Indeed, mutation of a tyrosine in the BH4 domain of Bcl-2,
Bcl-xL and Bcl-W has no effect on their ability to bind pro-apoptotic
members and prevent apoptosis whereas it abolishes their effect onTable 1
Table summarizing the non-apoptotic functions of the Bcl-2 family, their effect on Ca2+ hom
effect on cellular processes.
Non-apoptotic function Bcl-2 family member involved Effect on [Ca2+] Inter
Cell cycle Bcl-2, Bcl-xL, Bcl-W ↘ [Ca2+]c ↘ Ca
↗ p2
↘ Ca
↘ NF
Bax, Bak ↗ [Ca2+]ER ↗ Ca
↗ [Ca2+]c ↘ p2
Phosphorylated Bcl-2 ↗ [Ca2+]c ↗ Ca
Neuroplasticity Bcl-2 ↘ [Ca2+]ER ↗ Ca
↗ [Ca2+]c ↗ CR
↗ c-f
Immune response Bim ↗ [Ca2+]c ↗ Ca
Bax, Bak ↗ [Ca2+]ER
↗IICR ↗ NF
Cell migration and invasion Bcl-2 ↗ [Ca2+]c ↗ Ca
↗ AP
↗ M
Early embryonic development Mcl-1 ↗ [Ca2+]c ↗ Ca
Nrz ↘ [Ca2+]c ↘ M
↘ Acthe cell cycle [107]. Interestingly, this mutation seems also to perturb
the ability of Bcl-2 to decrease IICR [67]. Of note, reduction of ER Ca2+
level also induced an arrest in G1 phase correlated with increased p27
level [108]. Consistent with this result, Bax/Bak deﬁcient cells, known
to have lower ER Ca2+ content, exhibit higher level of p27 and are
slower to enter S phase compared to normal cells [109]. Finally,
inhibition of the Ca2+-dependent proteins Calmodulin, Calmodulin-
dependent kinases (CaMK) and Calcineurin could also lead to cell
cycle arrest early in G1 phase indicating that these proteins may be
involved in cell cycle progression through the G1 phase [110,111].
In particular, it has been shown that CaMKII can activate the MEK/
ERK pathway to promote p27 phosphorylation on the Thr187, a signal
for its degradation by the proteasome [112]. Furthermore, Calcineurin
is known to trigger NFAT dephosphorylation inducing its transloca-
tion to the nuclei and Bcl-2 overexpression decreases NFAT activity.
Thus, Bcl-2 and Bcl-xL may reduce the amount of Ca2+ released
from the ER by either decreasing ER Ca2+ content or directly
interacting with IP3R. As a consequence Bcl-2 and Bcl-xL could pre-
vent the activation of Ca2+-dependent proteins resulting in cell
cycle arrest whereas pro-apoptotic proteins would exert the opposite
effect.
Interestingly, Bcl-2 appears to be phosphorylated in a cell cycle
dependent manner. Indeed, Bcl-2 was found to be phosphorylated
during mitotic arrest induced by paclitaxel and decreasing Bcl-2
phosphorylation in cells arrested in mitosis promoted interphase
re-entry [113]. It has further been shown that such phosphorylation
normally occurs in mitosis when cyclinB1/CDK1 activity peaks
although this complex is not able to directly phosphorylate Bcl-2
[114]. Furthermore, phosphorylation of Bcl-2 was proposed to occur
in G2/M transition via the ASK1/JNK pathway, Bcl-2 being phosphor-
ylated on Ser70, Ser87 and Thr69 by JNK [115]. Of note, as mentioned
in Section 3.1, phosphorylation of Bcl-2 on these residues was
reported to act on ER Ca2+ homeostasis, as illustrated by the fact
that a non-phosphorylatable Bcl-2 mutant decreases Ca2+ released
from the ER [58]. Thus it can be assumed that phosphorylation of
Bcl-2 could increase cytosolic Ca2+concentration during the G2/M
transition and mitosis. On the other hand, there is a large body of
evidence showing that CaMKII activity is essential for progression
through the G2 and M phases of the cell cycle [111]. So, a plausible
hypothesis might be that phosphorylation of Bcl-2, by increasing
Ca2+ release from the ER, could participate in CaMKII activation
thus promoting cell cycle progression.eostasis, intermediate effectors involved in these pathways and ﬁnally the subsequent
mediate effectors Effect References
MK activity Arrest in G1 [4,90–92,95]
7 level
lcineurin activity
AT dependent transcription
MK activity Faster G1 [91,93,94]
7 level
MKII activity G2/M progression [101–103]
MK activity Neurite growth [109–114,116,117]
EB and Erk dependent transcription
os expression
lcineurin activity Lymphocyte activation [127]
[129]
AT dependent transcription
MK activity Cell invasion [131–134,136,137]
1 and NF-κB dependent transcription
MP-2/9 expression
lmodulin activity Embryo implantation [140]
LCK activity Epiboly progression [151,153]
tin-myosin contraction
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Neural plasticity, also known as neuroplasticity, refers to the
changes in structure, function and organization of the neuronal net-
work. This phenomenon has long been thought to be restricted to
the developing nervous system but it is now accepted that it occurs
in processes such as learning or memory as well as in recovery after
brain injury. Neuroplasticity is driven in part by the formation of
new synapses and thus requires the extension of neurites to reach
and form these new synapses.
Bcl-2 and Bcl-xL are expressed in the nervous system during em-
bryonic development as well as during the whole lifespan but they
harbor different spatial and temporal patterns of expression. Bcl-2
and Bcl-xL are both expressed in the developing central nervous sys-
tem (CNS). However, postnatally, Bcl-xL expression increases in the
CNS while Bcl-2 expression is reduced with aging, being almost re-
stricted to the peripheral nervous system (PNS) [116,117]. While
bcl-x knockout mice exhibit massive death of developing neurons
followed by embryonic death at day 13 [118], bcl-2 knockout mice
do not show any reduction in neuron number following the period
of naturally occurring cell death [119], suggesting that Bcl-xL is the
main regulator of neuronal apoptosis. On the other hand, it has
been shown that Bcl-2 can promote neurite outgrowth and regenera-
tion suggesting that Bcl-2 may play a role in neuroplasticity. Consis-
tently, Bcl-2 is strongly expressed in the developing CNS when
axons elongate and its expression declines as neurons lose their abil-
ity to generate new axons [120]. In adults its expression is maintained
in regions where postnatal neurogenesis takes place, such as the den-
tate gyrus of the cortex [116]. Thus, a number of studies have demon-
strated that Bcl-2 overexpression in CNS neurons promotes axonal
growth [121] while axonal elongation is reduced in neurons from
Bcl-2-deﬁcient mice [122,123]. Interestingly, Jiao and colleagues
demonstrated that the effect of Bcl-2 on axon elongation is dependent
on its ER localization and is mediated by the activation of Erk and
CREB transcriptional programs [124]. These programs appear to
be essential for the regulation of neurite extension and it is well
established that they can be activated by cytosolic [Ca2+] increase,
in part via CaMKs-dependent phosphorylation [125]. These authors
showed that in neurons, Bcl-2 reduces ER Ca2+ uptake, probably by
acting on SERCA, to enhance cytosolic Ca2+ level and then promote
axon elongation. Consistent with this result, measurement of intracel-
lular Ca2+ store content in PC12 cells by another group also revealed
that Bcl-2 decreases ER uptake, suggesting that, in CNS neurons, Bcl-2
may increase cytosolic Ca2+ level to promote axon elongation [84].
Furthermore, another publication strengthens the idea that Bcl-2
mediates axon elongation through CREB activation as Bcl-2 could in-
crease c-fos gene expression, one of the target genes of CREB required
for axonal elongation [126]. Finally, the effect of Bcl-2 on Ca2+
homeostasis may have a number of other consequences than CREB
activation as many components of the machinery required for axonal
elongation are Ca2+-sensitive [127]. In contrast with the results in
CNS neurons, Hansen and colleagues found that Bcl-2 overexpression
in spiral ganglion neurons inhibits neurites outgrowth [128]. More-
over, in a later study, they showed that this effect could be triggered
by Bcl-2 targeted either at the ER or at the mitochondria [129]. The
authors argued that this difference could rely on the fact that each
type of neuron has a different optimal intracellular [Ca2+] required
to promote neurite growth [127]. Thus, in spiral ganglion neuron,
Bcl-2, by acting on Ca2+ homeostasis at both ER and mitochondria,
may alter the intracellular [Ca2+] in a way that inhibits neurite
growth.
Of note, neural plasticity seems to be impaired in some patholo-
gies such as anxiety or bipolar disorders and some studies reveal
that Bcl-2 may be related to these pathologies [130,131]. In particular,
bipolar disorder is associated with perturbations in intracellular Ca2+
homeostasis and it was recently showed that a single nucleotidepolymorphism (SNP), which decreases Bcl-2 expression, is associated
with bipolar disorder [132,133]. Both studies demonstrate that this
SNP leads to alterations in intracellular Ca2+ homeostasis associated
with abnormal Ca2+ release through IP3R.
Thus, Bcl-2 appears to play a crucial role in neuroplasticity although
the underlying mechanism is unclear. However, Bcl-2 seems to be
implicated in the tight regulation of Ca2+ ﬂuxes required for neurite
elongation by acting at the ER, on both IP3R and SERCA, but also possibly
at the mitochondria.
5.3. Lymphocyte activation
Ca2+ is a crucial second messenger for lymphocyte activation and
proliferation following antigen binding to the T-Cell receptor (TCR) or
B-Cell receptor (BCR) [134]. Indeed, antigen binding on TCR and BCR,
forming the immune synapse, ﬁrst leads to IP3 generation and subse-
quent Ca2+ release through IP3R. This release induces depletion of the
ER Ca2+ store and then promotes the inﬂux of extracellular Ca2+
through the opening of the plasma membrane Ca2+-release activated
Ca2+ channels (CRAC) by a pathway commonly referred to as store-
operated Ca2+ entry (SOCE) [134,135]. It has also been shown that
mitochondria play a fundamental role in intracellular Ca2+ homeo-
stasis after immune synapse formation by moving to the plasma
membrane and uptaking some amount of Ca2+ to prevent high cyto-
solic [Ca2+] which leads to CRAC inactivation [136,137]. Finally, this
ﬁne intracellular Ca2+ regulation leads, among other, to the activa-
tion of Calcineurin which dephosphorylates and activates NFAT, a
critical step for T-cell activation and proliferation.
Beyond their known function in lymphocyte selection and devel-
opment by controlling apoptosis [138], Bcl-2 proteins might be in-
volved in Ca2+ homeostasis regulation in the immune cells thanks
to their ER and/or mitochondria localization. Indeed, recent studies
pointed out the role of Bcl-2 proteins in Ca2+ release from the ER
after T cell receptor activation. Thus the BH3-only protein, Bim, was
shown to be crucial for T-cell activation and proliferation [139]. In
this study authors demonstrated that T-cells from Bim−/− mice ex-
hibit lower ER Ca2+ release and subsequent NFAT dephosphorylation.
These severe defects seem to be correlated with an increase of the
Bcl-2/IP3R complex number, leading to partial ER depletion because
of the suppression of Bim destabilization effect on Bcl-2/IP3R interac-
tion. Also, a second team has shown that Bcl-2 could modulate Ca2+
release from the ER after strong T-cell activation, but not weak activa-
tion, suggesting that Ca2+ responses may have different require-
ments for the IP3R [140]. Thus, it is possible that Bcl-2 might be
implicated in these two different regulation pathways.
Moreover, the group of C. Thompson nicely demonstrated the
non-apoptotic role of Bax and Bak in the control of T-cell proliferation
by their ability to regulate ER Ca2+ release after TCR engagement
[141]. Their data indicated that T-cells lacking both Bax and Bak dis-
play defects in TCR- and IP3-inducible Ca2+ ﬂuxes from the ER. They
argued that decreased IICR is a consequence of ER Ca2+ store reduc-
tion in Bax−/− Bak−/− T cells. They also showed that Ca2+ dereg-
ulation leads to a decrease of ROS production which could also be
involved in T-cell proliferation.
Finally, another group demonstrated that Bcl-2 could regulate
plasma membrane Ca2+ ATPases (PMCA) function in pancreatic aci-
nar cells [142]. PMCA has a fundamental role in Ca2+ homeostasis
control near the CRAC after lymphocyte activation, avoiding CRAC
inactivation and thus permitting the SOCE process. We may then
hypothesize that during TCR activation, Bcl-2 might also regulate
Ca2+ extrusion by modulating PMCA function in T-cells.
Thus many studies have provided evidence that Ca2+ is crucial for
lymphocyte activation with the ER and the mitochondria playing cen-
tral roles. Given their ability to interact with IP3R and VDAC, Bcl-2
proteins might be important for IICR and mitochondrial Ca2+ buffer-
ing during lymphocyte activation.
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The deregulation of Bcl-2 family protein expression is often asso-
ciated with cell transformation as it allows tumor cells to escape
from apoptosis. However, some studies provide evidence that Bcl-2
proteins can also regulate cellular migration and invasion during
tumor progression. It was ﬁrst reported that the overexpression of
Bcl-2 enhances the metastatic potential of breast cancer cell line in
vivo and promotes cell migration and invasion in vitro [143]. Bcl-2
was further found to exert the same effect in human glioma malig-
nant cell line; this effect was attributed to an increased level of matrix
metalloproteinases (MMP) and in particular MMP-2 and MMP-9
[144]. MMPs are able to cleave components of the extracellular ma-
trix and are associated with tumor progression as they can degrade
the basement membrane allowing cells to form metastasis [145].
These results were conﬁrmed in non-small cell lung cancer cells
where Bcl-2 also promotes MMP-2 expression and activity [146].
These authors demonstrated that induction of MMP-2 expression is
driven here by the AP-1 transcription factor. Interestingly, it has
been proposed that elevation of intracellular Ca2+ level can promote
AP-1 formation via CaMK activation [147]. Thus Bcl-2 either by in-
creasing Ca2+ leak at the ER or by reducing Ca2+ uptake at the ER
and/or at the mitochondria could promote Ca2+ increase in the cyto-
sol and subsequent activation of the AP-1 transcriptional complex.
Furthermore, two studies showed that Bcl-2 may also promote the ac-
tivity of the NF-κB transcription factor which can in particular induce
MMP-9 expression [148,149]. As for AP-1 it has been reported that
intracellular Ca2+ increase can activate NF-κB [150]. Together these
data suggest that Bcl-2 may promote the activation of transcriptional
factors inducing expression of genes involved in migration and inva-
sion of tumor cells by regulating Ca2+ homeostasis.
Finally, cell migration is tightly linked to a ﬁne regulation of Ca2+
homeostasis within the cell. Indeed, it has been recently demonstrat-
ed that migration relies on Ca2+ gradients inside the cell which can
activate a large number of Ca2+-dependent proteins at the leading
edge of the migrating cell [151]. Given, the role of Bcl-2 proteins on
Ca2+ homeostasis it could be hypothesized that these proteins are
differently regulated or expressed within the migrating cell to partici-
pate in the formation of Ca2+ gradients and thus act on cell migration.
5.5. Early embryonic development
Apoptosis is an essential phenomenon during embryonic develop-
ment to control cellular homeostasis and shape the future body of the
developing embryo. In this regard, Bcl-2 proteins are highly expressed
during embryonic development and knockout of their related genes
are generally correlated with apoptosis defects during embryogenesis
[7]. However, some members of the family seem to exert alternative
functions going from oocyte maturation to the control of early embry-
onic development.
In particular,mcl-1 is one of the only members of the family which
knockout in mice is not correlated with apoptosis defect. Indeed, it
has been shown that mcl-1 null embryos do not harbor any sign of
increased apoptosis but these embryos fail to implant in utero and
exhibit a delay of maturation [152]. Interestingly, IP3-dependent Ca2+
release has been proposed to participate in mouse pre-implantation
development via the activation of Calmodulin [153]. In particular,
decreasing the intracellular Ca2+ level within the embryo seems to
delay the ﬁrst steps of embryonic development. Moreover, during
implantation the ﬁxation of blastocyst with ﬁbronectin induces a rise
in intracellular [Ca2+] and reducing the amount of intracellular Ca2+
during this process seems to impair implantation [154]. Furthermore,
so far the only study on Ca2+ regulation by Mcl-1 proposed that it en-
hanced Ca2+ release through IP3R upon physiological IP3 stimulation
[71]. Thus, in the mouse embryo, absence of Mcl-1 may decrease Ca2+
release from the ER then altering development and implantation.Among the anti-apoptotic members, orthologs of nr-13 seem to be
particularly important for reproduction and embryonic development.
Nr-13 was ﬁrst characterized as an anti-apoptotic protein in quail
neuroretina. Interestingly, nr-13 gene expression was shown to be
enhanced by the Rous sarcoma virus thus contributing to virus expan-
sion [155]. In chicken, Nr-13 was shown to be mainly expressed dur-
ing embryonic development in the bursa of Fabricius and in ovarian
follicles [156,157]. Later on, the mouse homolog, Diva/Boo [146] and
the humanhomolog, Nrh (also known as Bcl2l10) [158]were character-
ized. Of note, these two proteins are only expressed in ovaries and testis
[159,160]. In the ovary, Bcl2l10 is implicated in oocyte maturation
where it seems to control spindle formation, possibly by interacting
with the microtubule-binding protein TCTP [159,161,162]. More re-
cently, we have identiﬁed nrz as the zebraﬁsh ortholog of nr-13. Nrz is
highly expressed during the early embryonic development with a
speciﬁc pattern of expression [163]. Indeed, Nrz is found in an extra-
embryonic structure called the yolk syncytial layer (YSL), which results
from the merging of marginal cells of the embryo with the yolk sac be-
fore the onset of gastrulation. Interestingly, Nrz seems to be involved in
the ﬁrst morphogenetic movement of zebraﬁsh embryogenesis called
epiboly. This movement is characterized by themigration of embryonic
cells from the animal pole down to the vegetal pole of the embryo.
When nrz translation is repressed, embryos fail to undergo epiboly
and ﬁnally die from a detachment of the cells from the yolk sac without
any apoptosis activation [163,164]. Further characterization of this phe-
notype pointed out Ca2+ homeostasis alteration within the embryo
[165]. Nrz is in fact able to interact with IP3R and decrease Ca2+ release
through the channel. Thus, in the absence of Nrz, a large increase in
cytosolic Ca2+ level occurs during epiboly which activates the CaMK,
MLCK. This cascade leads to the hypercontraction of an actin–myosin
ring present at the margin of the migrating cells resulting in detach-
ment of the whole embryo from the yolk cell. Interestingly, the normal
actin–myosin ring contraction during epiboly is correlated with cyclic
Ca2+ waves, which cross the embryo in the YSL [166]. Therefore, re-
garding the function of Nrz at the ER and its impact on actin ring
contraction, we could speculate that during epiboly progression
Nrz/IP3R interaction may be modulated to generate these Ca2+ waves
[167].6. Conclusion
For the last two decades, Bcl-2 proteins function in apoptosis reg-
ulation at the mitochondria has been extensively studied although
certain mechanisms still remain unsolved. Moreover, it is now well
established that Ca2+, a second messenger crucial for many cellular
processes, is also involved in apoptosis and numerous studies empha-
size the role of Bcl-2 proteins on Ca2+ regulation in this process.
However, the mechanisms by which Bcl-2 proteins could regulate
Ca2+ homeostasis at both the ER and the mitochondria are poorly
understood and are still a matter of debate.
Beyond their involvement in apoptosis, a growing set of evidence
supports the idea that Bcl-2 proteins also possess non-apoptotic roles
as different as cell cycle regulation or neuroplasticity among other.
Here, we discussed the hypothesis according to which Ca2+ homeo-
stasis regulation may be a common mechanism underlying some of
these non-apoptotic functions of Bcl-2 proteins. Therefore, at the
light of these evidences, a better understanding of the mechanisms
by which Bcl-2 proteins control Ca2+ ﬂuxes within the cell could
allow us to decipher the large action range of this fascinating family.Acknowledgements
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